XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities
9 Months Ended
Sep. 30, 2021
Marketable Securities [Abstract]  
Marketable Securities

4. Marketable Securities

The following table summarizes the available-for-sale debt securities held at September 30, 2021 and December 31, 2020 and (in thousands):

 

Description

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury securities

 

$

179,723

 

 

$

23

 

 

$

(5

)

 

$

179,741

 

Corporate securities

 

 

274,682

 

 

 

5

 

 

 

(169

)

 

 

274,518

 

Total

 

$

454,405

 

 

$

28

 

 

$

(174

)

 

$

454,259

 

 

Description

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury securities

 

$

324,917

 

 

$

 

 

$

(53

)

 

$

324,864

 

Corporate securities

 

 

102,946

 

 

 

 

 

 

(81

)

 

 

102,865

 

Total

 

$

427,863

 

 

$

 

 

$

(134

)

 

$

427,729

 

 

 

As of September 30, 2021, the Company held 79 securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $286.6 million. As of December 31, 2020, the Company held 65 securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $392.2 million.

 

As of September 30, 2021, the Company had 77 securities with a fair value of $379.6 million with a contractual maturity of less than 12 months and 24 securities with a fair value of $74.7 million with a contractual maturity of greater than 12 months. As of December 31, 2020, the Company had 48 securities with a fair value of $295.6 million with a contractual maturity of less than 12 months and 25 securities with a fair value of $162.5 million with a contractual maturity of greater than 12 months. There were no sales of marketable securities during the three and nine months ending September 30, 2021 and 2020.

 

The Company evaluates securities for other-than-temporary impairments based on quantitative and qualitative factors, and considered the decline in market value for the 79 securities in an unrealized loss position as of September 30, 2021 to be primarily attributable to the then current economic and market conditions. The Company neither intends to sell these investments nor concludes that it is more-likely-than-not that the Company will have to sell them before recovery of their carrying values. The Company also believes that it will be able to collect both principal and interest amounts due to it at maturity.